Olivia Moses Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2400 Merton Ave, Eagle Rock, CA 90041 Phone: 517-331-2239 |
News Archive
Transave, Inc., today reported positive results from a Phase II clinical trial in non-cystic fibrosis (CF) bronchiectasis patients for its lead investigational drug, ARIKACE(TM) (liposomal amikacin for inhalation). The Phase II data indicated that ARIKACE, delivered once daily for 28 consecutive days, demonstrated superior clinical benefit compared to placebo as measured by patient and physician reported outcomes and reduction in Pseudomonas aeruginosa density.
Water-wasting and uncaring about gels, shampoos and soap going down the plughole: that's how the British emerge from a survey on showering habits of western Europeans.
To coincide with World Alzheimer's Month, EIT Health, an EU-backed network of best-in-class health innovators, has highlighted the urgent need to focus on implementing bolder approaches to the treatment of Alzheimer's Disease post-pandemic.
Today's teens and young people are abusing prescription painkillers more than any other age group or any other youth in history. Availability of these drugs from their parents' medicine cabinets may be to blame, according to new research in the Journal of Adolescent Health.
The anti-coagulant heparin reduces the likelihood of death from COVID-19 by 78% when administered in therapeutic doses to patients with signs of respiratory failure on admission to hospital, according to a study reported on October 14 in the British Medical Journal.
› Verified 3 days ago